DRIVE Trademark

Trademark Overview

On Tuesday, July 26, 2016, a trademark application was filed for DRIVE with the United States Patent and Trademark Office. The USPTO has given the DRIVE trademark a serial number of 87116365. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Tuesday, May 28, 2024. This trademark is owned by Durata Therapeutics Holding C.V.. The DRIVE trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Providing a registry of patients for whom the antibiotic dalbavancin has been prescribed which is used for gathering medical-related real world safety, effectiveness, and usage data; none of the above relating to or in the field of cancer treatment, cancer research, genomic research or gene sequencing
drive

General Information

Serial Number87116365
Word MarkDRIVE
Filing DateTuesday, July 26, 2016
Status710 - CANCELLED - SECTION 8
Status DateTuesday, May 28, 2024
Registration Number5336382
Registration DateTuesday, November 14, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 27, 2016

Trademark Statements

Goods and ServicesProviding a registry of patients for whom the antibiotic dalbavancin has been prescribed which is used for gathering medical-related real world safety, effectiveness, and usage data; none of the above relating to or in the field of cancer treatment, cancer research, genomic research or gene sequencing

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateTuesday, May 28, 2024
Primary Code044
First Use Anywhere DateFriday, March 31, 2017
First Use In Commerce DateFriday, March 31, 2017

Trademark Owner History

Party NameDurata Therapeutics Holding C.V.
Party Type30 - Original Registrant
Legal Entity Type13 - Limited Partnership
AddressGrand Cayman KY1-9005
KY
Party NameDurata Therapeutics Holding C.V.
Party Type20 - Owner at Publication
Legal Entity Type13 - Limited Partnership
AddressGrand Cayman KY1-9005
KY
Party NameDurata Therapeutics Holding C.V.
Party Type10 - Original Applicant
Legal Entity Type13 - Limited Partnership
AddressGrand Cayman KY1-9005
KY

Trademark Events

Event DateEvent Description
Wednesday, November 9, 2016EXAMINER'S AMENDMENT ENTERED
Friday, July 29, 2016NEW APPLICATION ENTERED
Friday, July 29, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, November 5, 2016ASSIGNED TO EXAMINER
Wednesday, November 9, 2016EXAMINERS AMENDMENT E-MAILED
Wednesday, November 9, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, November 9, 2016EXAMINERS AMENDMENT -WRITTEN
Wednesday, December 7, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, June 21, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, November 16, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 27, 2016PUBLISHED FOR OPPOSITION
Tuesday, December 27, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, January 23, 2017EXTENSION OF TIME TO OPPOSE RECEIVED
Wednesday, March 15, 2017TEAS POST PUBLICATION AMENDMENT RECEIVED
Friday, March 31, 2017ASSIGNED TO PETITION STAFF
Saturday, April 1, 2017CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Sunday, May 7, 2017EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Monday, September 11, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 10, 2017TEAS STATEMENT OF USE RECEIVED
Monday, July 10, 2017USE AMENDMENT FILED
Friday, August 4, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Saturday, August 5, 2017STATEMENT OF USE PROCESSING COMPLETE
Friday, August 25, 2017SU - NON-FINAL ACTION - WRITTEN
Friday, August 25, 2017NON-FINAL ACTION E-MAILED
Friday, August 25, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 29, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, September 10, 2017ASSIGNED TO LIE
Friday, October 13, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, November 14, 2017REGISTERED-PRINCIPAL REGISTER
Monday, November 14, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, May 28, 2024CANCELLED SEC. 8 (6-YR)
Thursday, October 12, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, September 11, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 5, 2017SU - NON-FINAL ACTION - WRITTEN
Thursday, October 5, 2017NON-FINAL ACTION E-MAILED
Thursday, October 5, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED

Related Keywords

drive research cancer none above data usage effectiveness relating field genomic